The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Neuro-Oncological Diseases Device Market Research Report 2025
Synopsis
Neuro-oncological diseases are the disorders that are typically caused due to the growth of a benign or malignant tumor in the brain or any part of the central nervous system. Neuro-oncological tumors are highly fatal, and so their diagnosis becomes a topic of foremost importance. There are a number of neuro-oncological diagnosis devices based on a variety of techniques for the diagnosis of neuro-oncological diseases.
The global Neuro-Oncological Diseases Device market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The market for neuro-oncological diagnosis devices is most developed in the North American and European region owing to the funds that government provides for research and development of high-quality neuro-oncological diagnosis devices. The market for the devices is also increasing rapidly in Asia Pacific due to new policies of governments which fascinates manufacturers for manufacturing neuro-oncological diagnosis devices in these countries. Neuro-oncological diagnosis device usage is obligatory in the diagnosis of fatal diseases. Therefore, many under-developed economies of middle east and Africa also have a large market for neuro-oncological diagnosis devices.
This report aims to provide a comprehensive presentation of the global market for Neuro-Oncological Diseases Device, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neuro-Oncological Diseases Device.
Report Scope
The Neuro-Oncological Diseases Device market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Neuro-Oncological Diseases Device market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Neuro-Oncological Diseases Device manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Siemens Healthcare
Philips Healthcare
Canon Medical Systems
GE Healthcare
Hitachi Medical
Segment by Type
MRI
CT Scan
PET
Others
Segment by Application
Hospitals
Clinics
Diagnostics Centers
Reference Laboratories
Medical Research Institutes
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Neuro-Oncological Diseases Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Neuro-Oncological Diseases Device in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Neuro-oncological diseases are the disorders that are typically caused due to the growth of a benign or malignant tumor in the brain or any part of the central nervous system. Neuro-oncological tumors are highly fatal, and so their diagnosis becomes a topic of foremost importance. There are a number of neuro-oncological diagnosis devices based on a variety of techniques for the diagnosis of neuro-oncological diseases.
The global Neuro-Oncological Diseases Device market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The market for neuro-oncological diagnosis devices is most developed in the North American and European region owing to the funds that government provides for research and development of high-quality neuro-oncological diagnosis devices. The market for the devices is also increasing rapidly in Asia Pacific due to new policies of governments which fascinates manufacturers for manufacturing neuro-oncological diagnosis devices in these countries. Neuro-oncological diagnosis device usage is obligatory in the diagnosis of fatal diseases. Therefore, many under-developed economies of middle east and Africa also have a large market for neuro-oncological diagnosis devices.
This report aims to provide a comprehensive presentation of the global market for Neuro-Oncological Diseases Device, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neuro-Oncological Diseases Device.
Report Scope
The Neuro-Oncological Diseases Device market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Neuro-Oncological Diseases Device market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Neuro-Oncological Diseases Device manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Siemens Healthcare
Philips Healthcare
Canon Medical Systems
GE Healthcare
Hitachi Medical
Segment by Type
MRI
CT Scan
PET
Others
Segment by Application
Hospitals
Clinics
Diagnostics Centers
Reference Laboratories
Medical Research Institutes
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Neuro-Oncological Diseases Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Neuro-Oncological Diseases Device in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Neuro-Oncological Diseases Device Market Overview
1.1 Product Overview and Scope of Neuro-Oncological Diseases Device
1.2 Neuro-Oncological Diseases Device Segment by Type
1.2.1 Global Neuro-Oncological Diseases Device Market Value Comparison by Type (2024-2030)
1.2.2 MRI
1.2.3 CT Scan
1.2.4 PET
1.2.5 Others
1.3 Neuro-Oncological Diseases Device Segment by Application
1.3.1 Global Neuro-Oncological Diseases Device Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Diagnostics Centers
1.3.5 Reference Laboratories
1.3.6 Medical Research Institutes
1.3.7 Others
1.4 Global Neuro-Oncological Diseases Device Market Size Estimates and Forecasts
1.4.1 Global Neuro-Oncological Diseases Device Revenue 2019-2030
1.4.2 Global Neuro-Oncological Diseases Device Sales 2019-2030
1.4.3 Global Neuro-Oncological Diseases Device Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Neuro-Oncological Diseases Device Market Competition by Manufacturers
2.1 Global Neuro-Oncological Diseases Device Sales Market Share by Manufacturers (2019-2024)
2.2 Global Neuro-Oncological Diseases Device Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Neuro-Oncological Diseases Device Average Price by Manufacturers (2019-2024)
2.4 Global Neuro-Oncological Diseases Device Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Neuro-Oncological Diseases Device, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Neuro-Oncological Diseases Device, Product Type & Application
2.7 Neuro-Oncological Diseases Device Market Competitive Situation and Trends
2.7.1 Neuro-Oncological Diseases Device Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Neuro-Oncological Diseases Device Players Market Share by Revenue
2.7.3 Global Neuro-Oncological Diseases Device Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Neuro-Oncological Diseases Device Retrospective Market Scenario by Region
3.1 Global Neuro-Oncological Diseases Device Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Neuro-Oncological Diseases Device Global Neuro-Oncological Diseases Device Sales by Region: 2019-2030
3.2.1 Global Neuro-Oncological Diseases Device Sales by Region: 2019-2024
3.2.2 Global Neuro-Oncological Diseases Device Sales by Region: 2025-2030
3.3 Global Neuro-Oncological Diseases Device Global Neuro-Oncological Diseases Device Revenue by Region: 2019-2030
3.3.1 Global Neuro-Oncological Diseases Device Revenue by Region: 2019-2024
3.3.2 Global Neuro-Oncological Diseases Device Revenue by Region: 2025-2030
3.4 North America Neuro-Oncological Diseases Device Market Facts & Figures by Country
3.4.1 North America Neuro-Oncological Diseases Device Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Neuro-Oncological Diseases Device Sales by Country (2019-2030)
3.4.3 North America Neuro-Oncological Diseases Device Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Neuro-Oncological Diseases Device Market Facts & Figures by Country
3.5.1 Europe Neuro-Oncological Diseases Device Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Neuro-Oncological Diseases Device Sales by Country (2019-2030)
3.5.3 Europe Neuro-Oncological Diseases Device Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Neuro-Oncological Diseases Device Market Facts & Figures by Country
3.6.1 Asia Pacific Neuro-Oncological Diseases Device Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Neuro-Oncological Diseases Device Sales by Country (2019-2030)
3.6.3 Asia Pacific Neuro-Oncological Diseases Device Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Neuro-Oncological Diseases Device Market Facts & Figures by Country
3.7.1 Latin America Neuro-Oncological Diseases Device Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Neuro-Oncological Diseases Device Sales by Country (2019-2030)
3.7.3 Latin America Neuro-Oncological Diseases Device Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Neuro-Oncological Diseases Device Market Facts & Figures by Country
3.8.1 Middle East and Africa Neuro-Oncological Diseases Device Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Neuro-Oncological Diseases Device Sales by Country (2019-2030)
3.8.3 Middle East and Africa Neuro-Oncological Diseases Device Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Neuro-Oncological Diseases Device Sales by Type (2019-2030)
4.1.1 Global Neuro-Oncological Diseases Device Sales by Type (2019-2024)
4.1.2 Global Neuro-Oncological Diseases Device Sales by Type (2025-2030)
4.1.3 Global Neuro-Oncological Diseases Device Sales Market Share by Type (2019-2030)
4.2 Global Neuro-Oncological Diseases Device Revenue by Type (2019-2030)
4.2.1 Global Neuro-Oncological Diseases Device Revenue by Type (2019-2024)
4.2.2 Global Neuro-Oncological Diseases Device Revenue by Type (2025-2030)
4.2.3 Global Neuro-Oncological Diseases Device Revenue Market Share by Type (2019-2030)
4.3 Global Neuro-Oncological Diseases Device Price by Type (2019-2030)
5 Segment by Application
5.1 Global Neuro-Oncological Diseases Device Sales by Application (2019-2030)
5.1.1 Global Neuro-Oncological Diseases Device Sales by Application (2019-2024)
5.1.2 Global Neuro-Oncological Diseases Device Sales by Application (2025-2030)
5.1.3 Global Neuro-Oncological Diseases Device Sales Market Share by Application (2019-2030)
5.2 Global Neuro-Oncological Diseases Device Revenue by Application (2019-2030)
5.2.1 Global Neuro-Oncological Diseases Device Revenue by Application (2019-2024)
5.2.2 Global Neuro-Oncological Diseases Device Revenue by Application (2025-2030)
5.2.3 Global Neuro-Oncological Diseases Device Revenue Market Share by Application (2019-2030)
5.3 Global Neuro-Oncological Diseases Device Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Siemens Healthcare
6.1.1 Siemens Healthcare Corporation Information
6.1.2 Siemens Healthcare Description and Business Overview
6.1.3 Siemens Healthcare Neuro-Oncological Diseases Device Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Siemens Healthcare Neuro-Oncological Diseases Device Product Portfolio
6.1.5 Siemens Healthcare Recent Developments/Updates
6.2 Philips Healthcare
6.2.1 Philips Healthcare Corporation Information
6.2.2 Philips Healthcare Description and Business Overview
6.2.3 Philips Healthcare Neuro-Oncological Diseases Device Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Philips Healthcare Neuro-Oncological Diseases Device Product Portfolio
6.2.5 Philips Healthcare Recent Developments/Updates
6.3 Canon Medical Systems
6.3.1 Canon Medical Systems Corporation Information
6.3.2 Canon Medical Systems Description and Business Overview
6.3.3 Canon Medical Systems Neuro-Oncological Diseases Device Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Canon Medical Systems Neuro-Oncological Diseases Device Product Portfolio
6.3.5 Canon Medical Systems Recent Developments/Updates
6.4 GE Healthcare
6.4.1 GE Healthcare Corporation Information
6.4.2 GE Healthcare Description and Business Overview
6.4.3 GE Healthcare Neuro-Oncological Diseases Device Sales, Revenue and Gross Margin (2019-2024)
6.4.4 GE Healthcare Neuro-Oncological Diseases Device Product Portfolio
6.4.5 GE Healthcare Recent Developments/Updates
6.5 Hitachi Medical
6.5.1 Hitachi Medical Corporation Information
6.5.2 Hitachi Medical Description and Business Overview
6.5.3 Hitachi Medical Neuro-Oncological Diseases Device Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Hitachi Medical Neuro-Oncological Diseases Device Product Portfolio
6.5.5 Hitachi Medical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Neuro-Oncological Diseases Device Industry Chain Analysis
7.2 Neuro-Oncological Diseases Device Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Neuro-Oncological Diseases Device Production Mode & Process
7.4 Neuro-Oncological Diseases Device Sales and Marketing
7.4.1 Neuro-Oncological Diseases Device Sales Channels
7.4.2 Neuro-Oncological Diseases Device Distributors
7.5 Neuro-Oncological Diseases Device Customers
8 Neuro-Oncological Diseases Device Market Dynamics
8.1 Neuro-Oncological Diseases Device Industry Trends
8.2 Neuro-Oncological Diseases Device Market Drivers
8.3 Neuro-Oncological Diseases Device Market Challenges
8.4 Neuro-Oncological Diseases Device Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Neuro-Oncological Diseases Device Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Neuro-Oncological Diseases Device Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Neuro-Oncological Diseases Device Market Competitive Situation by Manufacturers in 2023
Table 4. Global Neuro-Oncological Diseases Device Sales (Units) of Key Manufacturers (2019-2024)
Table 5. Global Neuro-Oncological Diseases Device Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Neuro-Oncological Diseases Device Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Neuro-Oncological Diseases Device Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Neuro-Oncological Diseases Device Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Neuro-Oncological Diseases Device, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Neuro-Oncological Diseases Device, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Neuro-Oncological Diseases Device, Product Type & Application
Table 12. Global Key Manufacturers of Neuro-Oncological Diseases Device, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Neuro-Oncological Diseases Device by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neuro-Oncological Diseases Device as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Neuro-Oncological Diseases Device Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Neuro-Oncological Diseases Device Sales by Region (2019-2024) & (Units)
Table 18. Global Neuro-Oncological Diseases Device Sales Market Share by Region (2019-2024)
Table 19. Global Neuro-Oncological Diseases Device Sales by Region (2025-2030) & (Units)
Table 20. Global Neuro-Oncological Diseases Device Sales Market Share by Region (2025-2030)
Table 21. Global Neuro-Oncological Diseases Device Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Neuro-Oncological Diseases Device Revenue Market Share by Region (2019-2024)
Table 23. Global Neuro-Oncological Diseases Device Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Neuro-Oncological Diseases Device Revenue Market Share by Region (2025-2030)
Table 25. North America Neuro-Oncological Diseases Device Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Neuro-Oncological Diseases Device Sales by Country (2019-2024) & (Units)
Table 27. North America Neuro-Oncological Diseases Device Sales by Country (2025-2030) & (Units)
Table 28. North America Neuro-Oncological Diseases Device Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Neuro-Oncological Diseases Device Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Neuro-Oncological Diseases Device Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Neuro-Oncological Diseases Device Sales by Country (2019-2024) & (Units)
Table 32. Europe Neuro-Oncological Diseases Device Sales by Country (2025-2030) & (Units)
Table 33. Europe Neuro-Oncological Diseases Device Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Neuro-Oncological Diseases Device Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Neuro-Oncological Diseases Device Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Neuro-Oncological Diseases Device Sales by Region (2019-2024) & (Units)
Table 37. Asia Pacific Neuro-Oncological Diseases Device Sales by Region (2025-2030) & (Units)
Table 38. Asia Pacific Neuro-Oncological Diseases Device Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Neuro-Oncological Diseases Device Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Neuro-Oncological Diseases Device Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Neuro-Oncological Diseases Device Sales by Country (2019-2024) & (Units)
Table 42. Latin America Neuro-Oncological Diseases Device Sales by Country (2025-2030) & (Units)
Table 43. Latin America Neuro-Oncological Diseases Device Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Neuro-Oncological Diseases Device Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Neuro-Oncological Diseases Device Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Neuro-Oncological Diseases Device Sales by Country (2019-2024) & (Units)
Table 47. Middle East & Africa Neuro-Oncological Diseases Device Sales by Country (2025-2030) & (Units)
Table 48. Middle East & Africa Neuro-Oncological Diseases Device Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Neuro-Oncological Diseases Device Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Neuro-Oncological Diseases Device Sales (Units) by Type (2019-2024)
Table 51. Global Neuro-Oncological Diseases Device Sales (Units) by Type (2025-2030)
Table 52. Global Neuro-Oncological Diseases Device Sales Market Share by Type (2019-2024)
Table 53. Global Neuro-Oncological Diseases Device Sales Market Share by Type (2025-2030)
Table 54. Global Neuro-Oncological Diseases Device Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Neuro-Oncological Diseases Device Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Neuro-Oncological Diseases Device Revenue Market Share by Type (2019-2024)
Table 57. Global Neuro-Oncological Diseases Device Revenue Market Share by Type (2025-2030)
Table 58. Global Neuro-Oncological Diseases Device Price (USD/Unit) by Type (2019-2024)
Table 59. Global Neuro-Oncological Diseases Device Price (USD/Unit) by Type (2025-2030)
Table 60. Global Neuro-Oncological Diseases Device Sales (Units) by Application (2019-2024)
Table 61. Global Neuro-Oncological Diseases Device Sales (Units) by Application (2025-2030)
Table 62. Global Neuro-Oncological Diseases Device Sales Market Share by Application (2019-2024)
Table 63. Global Neuro-Oncological Diseases Device Sales Market Share by Application (2025-2030)
Table 64. Global Neuro-Oncological Diseases Device Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Neuro-Oncological Diseases Device Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Neuro-Oncological Diseases Device Revenue Market Share by Application (2019-2024)
Table 67. Global Neuro-Oncological Diseases Device Revenue Market Share by Application (2025-2030)
Table 68. Global Neuro-Oncological Diseases Device Price (USD/Unit) by Application (2019-2024)
Table 69. Global Neuro-Oncological Diseases Device Price (USD/Unit) by Application (2025-2030)
Table 70. Siemens Healthcare Corporation Information
Table 71. Siemens Healthcare Description and Business Overview
Table 72. Siemens Healthcare Neuro-Oncological Diseases Device Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. Siemens Healthcare Neuro-Oncological Diseases Device Product
Table 74. Siemens Healthcare Recent Developments/Updates
Table 75. Philips Healthcare Corporation Information
Table 76. Philips Healthcare Description and Business Overview
Table 77. Philips Healthcare Neuro-Oncological Diseases Device Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. Philips Healthcare Neuro-Oncological Diseases Device Product
Table 79. Philips Healthcare Recent Developments/Updates
Table 80. Canon Medical Systems Corporation Information
Table 81. Canon Medical Systems Description and Business Overview
Table 82. Canon Medical Systems Neuro-Oncological Diseases Device Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. Canon Medical Systems Neuro-Oncological Diseases Device Product
Table 84. Canon Medical Systems Recent Developments/Updates
Table 85. GE Healthcare Corporation Information
Table 86. GE Healthcare Description and Business Overview
Table 87. GE Healthcare Neuro-Oncological Diseases Device Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. GE Healthcare Neuro-Oncological Diseases Device Product
Table 89. GE Healthcare Recent Developments/Updates
Table 90. Hitachi Medical Corporation Information
Table 91. Hitachi Medical Description and Business Overview
Table 92. Hitachi Medical Neuro-Oncological Diseases Device Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Hitachi Medical Neuro-Oncological Diseases Device Product
Table 94. Hitachi Medical Recent Developments/Updates
Table 95. Key Raw Materials Lists
Table 96. Raw Materials Key Suppliers Lists
Table 97. Neuro-Oncological Diseases Device Distributors List
Table 98. Neuro-Oncological Diseases Device Customers List
Table 99. Neuro-Oncological Diseases Device Market Trends
Table 100. Neuro-Oncological Diseases Device Market Drivers
Table 101. Neuro-Oncological Diseases Device Market Challenges
Table 102. Neuro-Oncological Diseases Device Market Restraints
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Neuro-Oncological Diseases Device
Figure 2. Global Neuro-Oncological Diseases Device Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Neuro-Oncological Diseases Device Market Share by Type in 2023 & 2030
Figure 4. MRI Product Picture
Figure 5. CT Scan Product Picture
Figure 6. PET Product Picture
Figure 7. Others Product Picture
Figure 8. Global Neuro-Oncological Diseases Device Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Neuro-Oncological Diseases Device Market Share by Application in 2023 & 2030
Figure 10. Hospitals
Figure 11. Clinics
Figure 12. Diagnostics Centers
Figure 13. Reference Laboratories
Figure 14. Medical Research Institutes
Figure 15. Others
Figure 16. Global Neuro-Oncological Diseases Device Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 17. Global Neuro-Oncological Diseases Device Market Size (2019-2030) & (US$ Million)
Figure 18. Global Neuro-Oncological Diseases Device Sales (2019-2030) & (Units)
Figure 19. Global Neuro-Oncological Diseases Device Average Price (USD/Unit) & (2019-2030)
Figure 20. Neuro-Oncological Diseases Device Report Years Considered
Figure 21. Neuro-Oncological Diseases Device Sales Share by Manufacturers in 2023
Figure 22. Global Neuro-Oncological Diseases Device Revenue Share by Manufacturers in 2023
Figure 23. The Global 5 and 10 Largest Neuro-Oncological Diseases Device Players: Market Share by Revenue in 2023
Figure 24. Neuro-Oncological Diseases Device Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 25. Global Neuro-Oncological Diseases Device Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 26. North America Neuro-Oncological Diseases Device Sales Market Share by Country (2019-2030)
Figure 27. North America Neuro-Oncological Diseases Device Revenue Market Share by Country (2019-2030)
Figure 28. U.S. Neuro-Oncological Diseases Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Canada Neuro-Oncological Diseases Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Europe Neuro-Oncological Diseases Device Sales Market Share by Country (2019-2030)
Figure 31. Europe Neuro-Oncological Diseases Device Revenue Market Share by Country (2019-2030)
Figure 32. Germany Neuro-Oncological Diseases Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. France Neuro-Oncological Diseases Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. U.K. Neuro-Oncological Diseases Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Italy Neuro-Oncological Diseases Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Russia Neuro-Oncological Diseases Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Asia Pacific Neuro-Oncological Diseases Device Sales Market Share by Region (2019-2030)
Figure 38. Asia Pacific Neuro-Oncological Diseases Device Revenue Market Share by Region (2019-2030)
Figure 39. China Neuro-Oncological Diseases Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Japan Neuro-Oncological Diseases Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. South Korea Neuro-Oncological Diseases Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. India Neuro-Oncological Diseases Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Australia Neuro-Oncological Diseases Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Taiwan Neuro-Oncological Diseases Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Indonesia Neuro-Oncological Diseases Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Thailand Neuro-Oncological Diseases Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Malaysia Neuro-Oncological Diseases Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Philippines Neuro-Oncological Diseases Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Latin America Neuro-Oncological Diseases Device Sales Market Share by Country (2019-2030)
Figure 50. Latin America Neuro-Oncological Diseases Device Revenue Market Share by Country (2019-2030)
Figure 51. Mexico Neuro-Oncological Diseases Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Brazil Neuro-Oncological Diseases Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Argentina Neuro-Oncological Diseases Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Middle East & Africa Neuro-Oncological Diseases Device Sales Market Share by Country (2019-2030)
Figure 55. Middle East & Africa Neuro-Oncological Diseases Device Revenue Market Share by Country (2019-2030)
Figure 56. Turkey Neuro-Oncological Diseases Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 57. Saudi Arabia Neuro-Oncological Diseases Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 58. UAE Neuro-Oncological Diseases Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 59. Global Sales Market Share of Neuro-Oncological Diseases Device by Type (2019-2030)
Figure 60. Global Revenue Market Share of Neuro-Oncological Diseases Device by Type (2019-2030)
Figure 61. Global Neuro-Oncological Diseases Device Price (USD/Unit) by Type (2019-2030)
Figure 62. Global Sales Market Share of Neuro-Oncological Diseases Device by Application (2019-2030)
Figure 63. Global Revenue Market Share of Neuro-Oncological Diseases Device by Application (2019-2030)
Figure 64. Global Neuro-Oncological Diseases Device Price (USD/Unit) by Application (2019-2030)
Figure 65. Neuro-Oncological Diseases Device Value Chain
Figure 66. Neuro-Oncological Diseases Device Production Process
Figure 67. Channels of Distribution (Direct Vs Distribution)
Figure 68. Distributors Profiles
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
